Skip to main navigation

Skip to content
Skip to primary sidebar
Skip to footer

240.243.1201
info@glycomimetics.com

Careers
Contact Us

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Year

August 9, 2021

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

August 5, 2021

GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2021

August 4, 2021

GlycoMimetics Names Harout Semerjian as New Chief Executive Officer to Succeed Retiring CEO Rachel King

July 29, 2021

GlycoMimetics to Report Second Quarter Financial Results on August 5, 2021

July 22, 2021

Trial Launches to Evaluate GlycoMimetics’ Uproleselan Added to Cladribine Plus Low-Dose Cytarabine in AML Patients

July 12, 2021

GlycoMimetics Announces Initiation of Clinical Trial Evaluating Uproleselan in Combination With Venetoclax and Azacitidine

May 27, 2021

GlycoMimetics to Present at Jefferies 2021 Virtual Healthcare Conference

May 26, 2021

GlycoMimetics Announces Investigator-Sponsored Phase 2 Clinical Trial Evaluating Uproleselan for Prevention of Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplantation

May 3, 2021

GlycoMimetics Reports Highlights and Financial Results for First Quarter 2021

April 26, 2021

GlycoMimetics to Report First Quarter Financial Results on May 3, 2021

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 29

Shareholder Tools

Print

Print
Printed Materials

Printed Materials
Email Alerts

Email Alerts
RSS

RSS
Search

Search

Footer

Questions?

Contact GlycoMimetics Today

Get in Touch

©2021 GlycoMimetics All rights reserved. Website Design & Development: Graphic Beans

Site Map | Terms of Use | Privacy | Contact Us